GB virus C coinfections in West African Ebola patients

Journal of Virology

Volumn 89, Issue 4, 2015, Pages 2425-2429

  Lauck, Michael ^a,b   Bailey, Adam L ^a,b   Andersen, Kristian G ^c,d   Goldberg, Tony L ^b,e   Sabeti, Pardis C ^c,d   O'Connora, David H ^b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN   (United States)

^c BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^d HARVARD UNIVERSITY   (United States)

^e UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; CLINICAL ARTICLE; CYTOKINE PRODUCTION; EBOLA HEMORRHAGIC FEVER; EBOLA VIRUS; EPIDEMIC; FEMALE; GENE DELETION; GENE INSERTION; GENE SEQUENCE; GUINEA; HEPATITIS G; HEPATITIS G VIRUS; HUMAN; IMMUNOMODULATION; LIBERIA; MALE; MIXED INFECTION; MORTALITY; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIERRA LEONE; SURVIVAL RATE; T LYMPHOCYTE ACTIVATION; VIREMIA; VIRUS DETECTION; VIRUS GENOME; VIRUS LOAD; VIRUS TRANSMISSION; ADOLESCENT; AGED; CHILD; COINFECTION; COMPLICATION; DNA SEQUENCE; FLAVIVIRIDAE INFECTIONS; GENETICS; HEPATITIS, VIRAL, HUMAN; INFANT; ISOLATION AND PURIFICATION; MIDDLE AGED; MOLECULAR GENETICS; NEWBORN; PRESCHOOL CHILD; SURVIVAL ANALYSIS; VERY ELDERLY; VIROLOGY; YOUNG ADULT;

EBOLA VIRUS; GB VIRUS C;

VIRUS RNA;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COINFECTION; FEMALE; FLAVIVIRIDAE INFECTIONS; GB VIRUS C; HEMORRHAGIC FEVER, EBOLA; HEPATITIS, VIRAL, HUMAN; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; SIERRA LEONE; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84921688418     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02752-14     Document Type: Article

References (46)

1. World Health Organization. 14 November 2014. Ebola response roadmap-situation report update. World Health Organization, Geneva, Switzerland. http://www.who.int/csr/disease/ebola/situation-reports/en/.
2. Gire SK, Goba A, Andersen KG, Sealfon RS, Park DJ, Kanneh L, Jalloh S, Momoh M, Fullah M, Dudas G, Wohl S, Moses LM, Yozwiak NL, Winnicki S, Matranga CB, Malboeuf CM, Qu J, Gladden AD, Schaffner SF, Yang X, Jiang PP, Nekoui M, Colubri A, Coomber MR, Fonnie M, Moigboi A, Gbakie M, Kamara FK, Tucker V, Konuwa E, Saffa S, Sellu J, Jalloh AA, Kovoma A, Koninga J, Mustapha I, Kargbo K, Foday M, Yillah M, Kanneh F, Robert W, Massally JL, Chapman SB, Bochicchio J, Murphy C, Nusbaum C, Young S, Birren BW, Grant DS, Scheiffelin JS, Lander ES, Happi C, Gevao SM, Gnirke A, Rambaut A, Garry RF, Khan SH, Sabeti PC. 2014. Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak. Science 345:1369-1372. http://dx.doi.org/10.1126/science.1259657.
3. Li C, Collini P, Danso K, Owusu-Ofori S, Dompreh A, Candotti D, Opare-Sem O, Allain JP. 2006. GB virus C and HIV-1 RNA load in single virus and co-infected West African individuals. AIDS 20:379-386. http://dx.doi.org/10.1097/01.aids.0000200536.79360.03.
4. Compston LI, Li C, Sarkodie F, Owusu-Ofori S, Opare-Sem O, Allain JP. 2009. Prevalence of persistent and latent viruses in untreated patients infected with HIV-1 from Ghana, West Africa. J Med Virol 81:1860-1868. http://dx.doi.org/10.1002/jmv.21614.
5. Sathar M, Soni P, York D. 2000. GB virus C/hepatitis G virus (GBV-C/HGV): still looking for a disease. Int J Exp Pathol 81:305-322. http://dx.doi.org/10.1046/j.1365-2613.2000.00166.x.
6. Mohr EL, Stapleton JT. 2009. GB virus type C interactions with HIV: the role of envelope glycoproteins. J Viral Hepat 16:757-768. http://dx.doi.org/10.1111/j.1365-2893.2009.01194.x.
7. Stapleton JT, Foung S, Muerhoff AS, Bukh J, Simmonds P. 2011. The GB viruses: a review and proposed classification of GBV-A, GBV-C (HGV), and GBV-D in genus Pegivirus within the family Flaviviridae. J Gen Virol 92:233-246. http://dx.doi.org/10.1099/vir.0.027490-0.
8. Alter HJ. 1997. G-pers creepers, where'd you get those papers? A reassessment of the literature on the hepatitis G virus. Transfusion 37:569-572.
9. Williams CF, Klinzman D, Yamashita TE, Xiang J, Polgreen PM, Rinaldo C, Liu C, Phair J, Margolick JB, Zdunek D, Hess G, Stapleton JT. 2004. Persistent GB virus C infection and survival in HIV-infected men. N Engl J Med 350:981-990. http://dx.doi.org/10.1056/NEJMoa030107.
10. Xiang J, Wünschmann S, Diekema DJ, Klinzman D, Patrick KD, George SL, Stapleton JT. 2001. Effect of coinfection with GB virus C on survival among patients with HIV infection. N Engl J Med 345:707-714. http://dx.doi.org/10.1056/NEJMoa003364.
11. Vahidnia F, Petersen M, Stapleton JT, Rutherford GW, Busch M, Custer B. 2012. Acquisition of GB virus type C and lower mortality in patients with advanced HIV disease. Clin Infect Dis 55:1012-1019. http://dx.doi.org/10.1093/cid/cis589.
12. Tillmann HL, Heiken H, Knapik-Botor A, Heringlake S, Ockenga J, Wilber JC, Goergen B, Detmer J, McMorrow M, Stoll M, Schmidt RE, Manns MP. 2001. Infection with GB virus C and reduced mortality among HIV-infected patients. N Engl J Med 345:715-724. http://dx.doi.org/10.1056/NEJMoa010398.
13. Zhang W, Chaloner K, Tillmann HL, Williams CF, Stapleton JT. 2006. Effect of early and late GB virus C viraemia on survival of HIV-infected individuals: a meta-analysis. HIV Med 7:173-180. http://dx.doi.org/10.1111/j.1468-1293.2006.00366.x.
14. Bhattarai N, Stapleton JT. 2012. GB virus C: the good boy virus? Trends Microbiol 20:124-130. http://dx.doi.org/10.1016/j.tim.2012.01.004.
15. Tucker TJ, Smuts HE. 2000. GBV-C/HGV genotypes: proposed nomenclature for genotypes 1-5. J Med Virol 62:82-83. http://dx.doi.org/10.1002/1096-9071(200009)62:1<82::AID-JMV12>3.0.CO;2-J.
16. Schieffelin JS, Shaffer JG, Goba A, Gbakie M, Gire SK, Colubri A, Sealfon RS, Kanneh L, Moigboi A, Momoh M, Fullah M, Moses LM, Brown BL, Andersen KG, Winnicki S, Schaffner SF, Park DJ, Yozwiak NL, Jiang PP, Kargbo D, Jalloh S, Fonnie M, Sinnah V, French I, Kovoma A, Kamara FK, Tucker V, Konuwa E, Sellu J, Mustapha I, Foday M, Yillah M, Kanneh F, Saffa S, Massally JL, Boisen ML, Branco LM, Vandi MA, Grant DS, Happi C, Gevao SM, Fletcher TE, Fowler RA, Bausch DG, Sabeti PC, Khan SH, Garry RF. 2014. Clinical illness and outcomes in patients with Ebola in Sierra Leone. N Engl J Med 371: 2092-2100. http://dx.doi.org/10.1056/NEJMoa1411680.
17. Sibley SD, Lauck M, Bailey AL, Hyeroba D, Tumukunde A, Weny G, Chapman CA, O'Connor DH, Goldberg TL, Friedrich TC. 2014. Discovery and characterization of distinct simian pegiviruses in three wild African Old World monkey species. PLoS One 9:e98569. http://dx.doi.org/10.1371/journal.pone.0098569.
18. Lauck M, Sibley SD, Hyeroba D, Tumukunde A, Weny G, Chapman CA, Ting N, Switzer WM, Kuhn JH, Friedrich TC, O'Connor DH, Goldberg TL. 2013. Exceptional simian hemorrhagic fever virus diversity in a Wild African primate community. J Virol 87:688-691. http://dx.doi.org/10.1128/JVI.02433-12.
19. Bailey AL, Lauck M, Weiler A, Sibley SD, Dinis JM, Bergman Z, Nelson CW, Correll M, Gleicher M, Hyeroba D, Tumukunde A, Weny G, Chapman C, Kuhn JH, Hughes AL, Friedrich TC, Goldberg TL, O'Connor DH. 2014. High genetic diversity and adaptive potential of two simian hemorrhagic fever viruses in a wild primate population. PLoS One 9:e90714. http://dx.doi.org/10.1371/journal.pone.0090714.
20. Bailey AL, Lauck M, Sibley SD, Pecotte J, Rice K, Weny G, Tumukunde A, Hyeroba D, Greene J, Correll M, Gleicher M, Friedrich TC, Jahrling PB, Kuhn JH, Goldberg TL, Rogers J, O'Connor DH. 3 September 2014. Two novel simian arteriviruses in captive and wild baboons (Papio spp.). J Virol http://dx.doi.org/10.1128/JVI.02203-14.
21. Villinger F, Rollin PE, Brar SS, Chikkala NF, Winter J, Sundstrom JB, Zaki SR, Swanepoel R, Ansari AA, Peters CJ. 1999. Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection. J Infect Dis 179(Suppl 1):S188-S191. http://dx.doi.org/10.1086/514283.
22. Geisbert TW, Hensley LE, Gibb TR, Steele KE, Jaax NK, Jahrling PB. 2000. Apoptosis induced in vitro and in vivo during infection by Ebola and Marburg viruses. Lab Invest 80:171-186. http://dx.doi.org/10.1038/labinvest.3780021.
23. Baize S, Leroy EM, Georges AJ, Georges-Courbot MC, Capron M, Bedjabaga I, Lansoud-Soukate J, Mavoungou E. 2002. Inflammatory responses in Ebola virus-infected patients. Clin Exp Immunol 128:163-168. http://dx.doi.org/10.1046/j.1365-2249.2002.01800.x.
24. Hensley LE, Young HA, Jahrling PB, Geisbert TW. 2002. Proinflammatory response during Ebola virus infection of primate models: possible involvement of the tumor necrosis factor receptor superfamily. Immunol Lett 80:169-179. http://dx.doi.org/10.1016/S0165-2478(01)00327-3.
25. Sanchez A, Lukwiya M, Bausch D, Mahanty S, Sanchez AJ, Wagoner KD, Rollin PE. 2004. Analysis of human peripheral blood samples from fatal and nonfatal cases of Ebola (Sudan) hemorrhagic fever: cellular responses, virus load, and nitric oxide levels. J Virol 78:10370-10377. http://dx.doi.org/10.1128/JVI.78.19.10370-10377.2004.
26. Baize S, Leroy EM, Georges-Courbot MC, Capron M, Lansoud-Soukate J, Debre P, Fisher-Hoch SP, McCormick JB, Georges AJ. 1999. Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients. Nat Med 5:423-426. http://dx.doi.org/10.1038/7422.
27. Ignatiev GM, Dadaeva AA, Luchko SV, Chepurnov AA. 2000. Immune and pathophysiological processes in baboons experimentally infected with Ebola virus adapted to guinea pigs. Immunol Lett 71:131-140. http://dx.doi.org/10.1016/S0165-2478(99)00169-8.
28. Ryabchikova EI, Kolesnikova LV, Luchko SV. 1999. An analysis of features of pathogenesis in two animal models of Ebola virus infection. J Infect Dis 179:S199-S202. http://dx.doi.org/10.1086/514293.
29. Geisbert TW, Hensley LE, Larsen T, Young HA, Reed DS, Geisbert JB, Scott DP, Kagan E, Jahrling PB, Davis KJ. 2003. Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection. Am J Pathol 163:2347-2370. http://dx.doi.org/10.1016/S0002-9440(10)63591-2.
30. Geisbert TW, Young HA, Jahrling PB, Davis KJ, Larsen T, Kagan E, Hensley LE. 2003. Pathogenesis of Ebola hemorrhagic fever in primate models: evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells. Am J Pathol 163:2371-2382. http://dx.doi.org/10.1016/S0002-9440(10)63592-4.
31. Feldmann H, Bugany H, Mahner F, Klenk HD, Drenckhahn D, Schnittler HJ. 1996. Filovirus-induced endothelial leakage triggered by infected monocytes/macrophages. J Virol 70:2208-2214.
32. Chivero ET, Bhattarai N, Rydze RT, Winters MA, Holodniy M, Stapleton J. 2014. Human Pegivirus (HPgV or GB virus C) RNA is found in multiple blood mononuclear cells in vivo and serum-derived viral RNA containing particles are infectious in vitro. J Gen Virol 95:1307-1319. http://dx.doi.org/10.1099/vir.0.063016-0.
33. George SL, Varmaz D, Stapleton JT. 2006. GB virus C replicates in primary T and B lymphocytes. J Infect Dis 193:451-454. http://dx.doi.org/10.1086/499435.
34. Bhattarai N, McLinden JH, Xiang J, Landay AL, Chivero ET, Stapleton JT. 2013. GB virus C particles inhibit T cell activation via envelope E2 protein-mediated inhibition of TCR signaling. J Immunol 190:6351-6359. http://dx.doi.org/10.4049/jimmunol.1300589.
35. Bhattarai N, McLinden JH, Xiang J, Kaufman TM, Stapleton JT. 2012. GB virus C envelope protein E2 inhibits TCR-induced IL-2 production and alters IL-2-signaling pathways. J Immunol 189:2211-2216. http://dx.doi.org/10.4049/jimmunol.1201324.
36. Bhattarai N, Rydze RT, Chivero ET, Stapleton JT. 2012. GB virus C viremia is associated with higher levels of double-negative T cells and lower T-cell activation in HIV-infected individuals receiving antiretroviral therapy. J Infect Dis 206:1469-1472. http://dx.doi.org/10.1093/infdis/jis515.
37. Maidana-Giret MT, Silva TM, Sauer MM, Tomiyama H, Levi JE, Bassichetto KC, Nishiya A, Diaz RS, Sabino EC, Palacios R, Kallas EG. 2009. GB virus typeCinfection modulates T-cell activation independently of HIV-1 viral load. AIDS 23:2277-2287. http://dx.doi.org/10.1097/QAD.0b013e32832d7a11.
38. Moenkemeyer M, Schmidt RE, Wedemeyer H, Tillmann HL, Heiken H. 2008. GBV-C coinfection is negatively correlated to Fas expression and Fas-mediated apoptosis in HIV-1 infected patients. J Med Virol 80:1933-1940. http://dx.doi.org/10.1002/jmv.21305.
39. Nattermann J, Nischalke H-D, Kupfer B, Rockstroh J, Hess L, Sauerbruch T, Spengler U. 2003. Regulation of CC chemokine receptor 5 in hepatitisGvirus infection. AIDS 17:1457-1462. http://dx.doi.org/10.1097/00002030-200307040-00006.
40. Rydze RT, Xiang J, McLinden JH, Stapleton JT. 2012. GB virus type C infection polarizes T-cell cytokine gene expression toward a Th1 cytokine profile via NS5A protein expression. J Infect Dis 206:69-72. http://dx.doi.org/10.1093/infdis/jis312.
41. Schwarze-Zander C, Neibecker M, Othman S, Tural C, Clotet B, Blackard JT, Kupfer B, Luechters G, Chung RT, Rockstroh JK, Spengler U. 2010. GB virus C coinfection in advanced HIV type-1 disease is associated with low CCR5 and CXCR4 surface expression on CD4(+) T-cells. Antivir Ther 15:745-752. http://dx.doi.org/10.3851/IMP1602.
42. Stapleton JT, Chaloner K, Martenson JA, Zhang J, Klinzman D, Xiang J, Sauter W, Desai SN, Landay A. 2012. GB virus C infection is associated with altered lymphocyte subset distribution and reduced T cell activation and proliferation in HIV-infected individuals. PLoS One 7:e50563-e50563. http://dx.doi.org/10.1371/journal.pone.0050563.
43. Xiang J, George SL, Wünschmann S, Chang Q, Klinzman D, Stapleton JT. 2004. Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1alpha, MIP-1beta, and SDF-1. Lancet 363: 2040-2046. http://dx.doi.org/10.1016/S0140-6736(04)16453-2.
44. Stapleton JT, Martinson JA, Klinzman D, Xiang J, Desai SN, Landay A. 2013. GB virus C infection and B-cell, natural killer cell, and monocyte activation markers in HIV-infected individuals. AIDS 27:1829-1832. http://dx.doi.org/10.1097/QAD.0b013e328363089f.
45. Vogel G. 28 August 2014. Ebola's heavy toll on study authors. ScienceInsider http://news.sciencemag.org/health/2014/08/ebolas-heavy-toll-study-authors.
46. Developmental Core Team R. 2014. R: a language and environment for statistical computing. R Development Core Team, Vienna, Austria.